Endothelin in atherosclerosis: Importance of risk factors and therapeutic implications

Journal of Cardiovascular Pharmacology

Volumn 35, Issue SUPPL. 2, 2000, Pages

  D'Uscio, L V ^a   Barton, M ^a   Shaw, S ^a   Luscher, T F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Atherosclerosis; Endothelin (ET); Endothelin receptor antagonists; Endothelium

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; NITRIC OXIDE; RECEPTOR SUBTYPE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE ACTIVATION; HYPERCHOLESTEROLEMIA; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR SMOOTH MUSCLE;

AGING; ARTERIOSCLEROSIS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; RECEPTORS, ENDOTHELIN; RISK FACTORS; VASOCONSTRICTION;

EID: 0033659681     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200000002-00013     Document Type: Review

References (29)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. Polar secretion of endothelin-1 by cultured endothelial cells
3. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop
4. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
5. Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide
6. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin
7. Endothelium-derived contracting factors
8. ET(A) and ET(B) receptors mediate contractions to endothelin-1 in renal artery of aging SHR: Effects of FR139317 and Bosentan
9. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries
10. Angiotensin II increases tissue endothelin and induces vascular hypertrophy: Reversal by ET(A)-receptor antagonist
11. Differential modulation of the renal and myocardial endothelin system by angiotensin II in vivo
12. Effects of chronic ET(A)-receptor blockade in angiotensin II-induced hypertension
13. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: Role of ET(A)-receptors for endothelin regulation
14. Structure and function of small arteries in salt-induced hypertension: Effects of chronic endothelin-subtype-A receptor blockade
15. ET(A)-receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy and endothelial dysfunction in salt-sensitive hypertension
16. Alterations of vascular reactivity in atherosclerosis
17. The two-receptor model of lipoprotein clearance: Tests of the hypothesis in 'knockout' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins
18. Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries: Role of scavenger receptor and endothelium-derived nitric oxide
19. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries
20. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
21. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium
22. Involvement of endothelin subtype A receptor in vascular smooth muscle cells proliferation evoked by oxidized low-density lipoprotein
23. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans
24. Anatomic heterogeneity of vascular aging: Role of nitric oxide and endothelin
25. Structure and reactivity of small arteries in aging
26. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
27. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol
28. Endothelin ET(A) receptor blockade restores NO-mediated endothelial dysfunction and inhibits atherosclerosis in apolipoprotein E-deficient mice